Seebri and Seizures - a phase IV clinical study of FDA data

Summary:

Seizures is reported as a side effect among people who take Seebri (glycopyrrolate), especially for people who are female, 60+ old, also take Xolair, and have Asthma.

The phase IV clinical study analyzes which people have Seizures when taking Seebri. It is created by eHealthMe based on reports of 2,613 people who have side effects when taking Seebri from the FDA, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Seizures?

Seizures (abnormal excessive or synchronous neuronal activity in the brain) is found to be associated with 1,994 drugs and 2,278 conditions by eHealthMe. Check the latest studies of Seizures.

On Jul, 20, 2026

2,613 people reported to have side effects when taking Seebri.
Among them, 14 people (0.54%) have Seizures.

Among these 14 people:

What is the gender of people who have Seizures when taking Seebri? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Seizures when taking Seebri? *

What are other drugs people take besides Seebri? *

Xolair: 6 people, 42.86%
Ventolin: 5 people, 35.71%
Symbicort: 4 people, 28.57%
Morphine: 4 people, 28.57%
Flovent: 4 people, 28.57%
Xarelto: 2 people, 14.29%
Tobramycin And Dexamethasone: 2 people, 14.29%
Nexium: 2 people, 14.29%
Depakote Er: 2 people, 14.29%
Depakene: 2 people, 14.29%

What are other side effects people have besides Seizures? *

Nausea And Vomiting: 10 people, 71.43%
Pneumonia: 9 people, 64.29%
Fatigue (feeling of tiredness): 8 people, 57.14%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 50.00%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 35.71%
Chills (felling of cold): 5 people, 35.71%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 35.71%
Consciousness - Decreased: 5 people, 35.71%
Diarrhea: 5 people, 35.71%
Headache (pain in head): 5 people, 35.71%

What are the existing conditions these people have? *

Asthma: 8 people, 57.14%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 14.29%
High Blood Cholesterol: 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.14%
Bronchial Carcinoma (lung cancer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and have Seizures?

- Check whether Seizures is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seebri:

Seebri (2,618 reports)

Seizures treatments and more:

Seizures (150,179 reports)

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seizures:

Seizures (1,994 drugs)

Browse all the conditions that are associated with Seizures:

Seizures (2,278 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Seebri) and Seebri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.